Clinical central lab - protocols 23-0005, 22-0011, 23-0006.
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Cerba Research Usa, Inc. UEI W15NDJ1DSXN9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $529,892
Award facts
- Contract value 100% obligated
- $529,892.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New Hyde Park, NY 11042, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $529,892 |
About this award
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Cerba Research USA, Inc., a for-profit organization. The $529,892 award will fund clinical central laboratory services in support of three NIAID clinical protocols related to infectious diseases. This work will be performed at Cerba Research's facility in New Hyde Park, New York. The award is not associated with a set-aside program and has a period of performance through September 30, 2025.
Cerba Research USA holds a larger $5 million single-award indefinite delivery contract with NIAID to provide clinical central laboratory services for the institute's vaccine and therapeutic clinical trials program. Two delivery orders totaling over $2 million have previously been issued under this vehicle for SARS-CoV-2 testing and general clinical trial support services.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Cerba Research Usa, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 18, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $529,892 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under 75N93021D00021, an indefinite delivery contract.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award